MIAT and diabetic kidney disease: In 2021, researchers observed that the lncRNA MIAT was noticeably upregulated in the plasma and kidney tissues of patients with diabetic nephropathy, and this upregulation correlated with higher albumin/creatinine ratios and serum creatinine levels.